Lateral flow assays market to hit $15.68b by 2033

Clinical testing remained the leading application segment in 2024.

The lateral flow assays market is expected to reach $15.68b by 2033 at a compound annual growth rate of 8.6%, said DataM Intelligence 4 Market Research LLP.

The sector’s expansion is attributed to the rising prevalence of infectious diseases, increased demand for point-of-care testing, and expanding applications across clinical diagnostics.

“Their adoption surged globally during the COVID-19 pandemic, and the momentum has continued with innovations in sandwich assays, multiplex detection formats, and portable lateral flow readers,” the report said.

By application, clinical testing remained the leading segment in 2024, generating over $ 3.1b in revenue.